|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2024
12 months to Dec 31, 2023
|
FY2023
10 months to Dec 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net Income (Loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Interest income on investments held in Trust Account | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Non-cash interest | |||||
| Registered Share Offering Costs | |||||
| Change in fair value of Forward Purchase Agreement | |||||
| Change in Warrant liability | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses | |||||
| Accounts receivable | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Accrued expenses -related party | |||||
| Prepaid income taxes | |||||
| Operating leases | |||||
| Net cash used in operating activities | |||||
| Cash Flows used in Investing Activities: | |||||
| Investment of cash in Trust Account | |||||
| Proceeds from Trust Account to pay taxes | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Finance lease payments | |||||
| Proceeds from issuance of Convertible debentures | |||||
| Outflow from Business Combination | |||||
| Repayment of Term loan | |||||
| Net Proceeds from Sales Agreement | |||||
| Proceeds from RDO I | |||||
| RDO I Costs | |||||
| Proceeds from RDO II | |||||
| RDO II Costs | |||||
| Proceeds from Class A Ordinary Shares to be Issued | |||||
| Proceeds from Registered Securities Offering | |||||
| Registered Share Offering Costs | |||||
| Proceeds from sale of Placement Units | |||||
| Proceeds from sale of Units, net of underwriting discount paid | |||||
| Proceeds from stock subscriptions received | |||||
| Repayment of Promissory note - related party | |||||
| Proceeds of Promissory note - related party | |||||
| Payment of offering costs | |||||
| Proceeds from exercise of stock options | |||||
| Net Proceeds from Issuance of Class A Ordinary shares | |||||
| Net Proceeds from Issuance of Preferred Shares | |||||
| Proceeds from Warrants exercised | |||||
| Net cash provided by financing activities | |||||
| Cash - Beginning of period | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents - Beginning of year | |||||
| Cash and Cash Equivalents - End of year | |||||
| Initial measurement of forward purchase options liabilities | |||||
| Accretion of Class A ordinary shares subject to redemption value | |||||
| Valuation of Representative Shares | |||||
| Offering costs included in Accrued offering costs | |||||
| Deferred underwriting fee payable | |||||
| Cash paid for income taxes | |||||
| Conversion of Convertible debentures | |||||
| Interest paid | |||||
Loading...